Clozapine causes a robust reduction in hepatic ceramide and sphingomyelin levels, coupled with a potentially compensatory upregulation of ceramide synthesising enzymes (CerS2 and ELOVL-1), in the presence of hyperglycemia and evidence of hepatic ER stress. Here, CERS2 is linked to Hyperglycemia.